Submitted by Anonymous (not verified) on 25 March 2025 - 16:30
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised